![](https://www.pdfsearch.io/img/7caf38f0d8fe773e8aeb6008acbf39d2.jpg) Date: 2012-10-24 19:18:58
| | Retraction Pfizer, Inc., has recently learned that the overall response rate and progression-free survival data published in “Phase II Study of the Anti–Insulin-Like Growth Factor Type 1 Receptor Antibody CP-751,871
Document is deleted from original location. Use the Download Button below to download from the Web Archive.Download Document from Web Archive File Size: 31,93 KB |